Literature DB >> 3227034

Behavioral effects of acute and chronic administration of caffeine in the rat.

S E File1, H A Baldwin, A L Johnston, L J Wilks.   

Abstract

This study investigated the effects of acute and chronic caffeine treatment on behavior in the social interaction, holeboard and home-cage aggression tests and on proconvulsant actions with pentylenetetrazol. Acutely-treated rats received an IP injection of caffeine (20 or 40 mg/kg). Chronically-treated rats received caffeine in their drinking water for 21 days (50 or 100 mg/kg/day) followed by an injection of caffeine on the test day (20 or 40 mg/kg respectively). Acutely, the higher dose of caffeine (40 mg/kg) decreased levels of social interaction. In the holeboard test, 20 mg/kg of acute caffeine increased motor activity whilst 40 mg/kg reduced head-dipping behavior. In the home-cage aggression test, acute caffeine (40 mg/kg) reduced offensive aggressive behaviors. After chronic treatment with caffeine none of these behaviors differed significantly from controls. After both acute and chronic treatment, caffeine (20 and 40 mg/kg) was proconvulsant with pentylenetetrazol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3227034     DOI: 10.1016/0091-3057(88)90104-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.

Authors:  G Griebel; M Saffroy-Spittler; R Misslin; D Remmy; E Vogel; J J Bourguignon
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Injection of Cocaine-Amphetamine Regulated Transcript (CART) peptide into the nucleus accumbens does not inhibit caffeine-induced locomotor activity: Implications for CART peptide mechanism.

Authors:  Martin O Job
Journal:  Pharmacol Biochem Behav       Date:  2016-05-07       Impact factor: 3.533

3.  Caffeine-induced behavioural stimulation is dose- and concentration-dependent.

Authors:  G B Kaplan; N T Tai; D J Greenblatt; R I Shader
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

Review 4.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

5.  Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice.

Authors:  G Griebel; M Saffroy-Spittler; R Misslin; E Vogel; J R Martin
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Caffeine augmentation of electroconvulsive seizures.

Authors:  A Francis; L Fochtmann
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

7.  Effects of anxiogenic drugs on the emission of 22- and 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Maria Willadsen; Laura M Best; Markus Wöhr; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

8.  Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine.

Authors:  H Zangrossi; J R Leite; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.

Authors:  Tonya N Taylor; W Michael Caudle; Kennie R Shepherd; AliReza Noorian; Chad R Jackson; P Michael Iuvone; David Weinshenker; James G Greene; Gary W Miller
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

10.  Acute effect of cola and caffeine on locomotor activity in drosophila and rat.

Authors:  K Kmeťová; M Marônek; V Borbélyová; J Hodosy; P Celec
Journal:  Physiol Res       Date:  2021-04-30       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.